Narrative Exposure Therapy in Patients With Posttraumatic Stress Disorder and Borderline Personality Disorder in a Naturalistic Residential Setting: A Randomized Controlled Trial
Steuwe C, Berg M, Beblo T, Driessen M (2021)
Frontiers in Psychiatry 12: 765348.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
fpsyt-12-765348.pdf
1.56 MB
Einrichtung
Abstract / Bemerkung
Background: Comorbid Posttraumatic Stress Disorder (PTSD) increases the already high symptom burden of patients with Borderline Personality Disorder (BPD). As the gold standard for BPD treatment, Dialectical Behavior Therapy (DBT), does not focus on PTSD, other treatment approaches are needed. Narrative Exposure Therapy (NET) was designed to address multiple traumatic events and may be especially useful in this patient group. The aim of the present study was to determine the efficacy of NET compared to DBT based treatment (DBT-bt) in a randomized controlled trial.
Methods: Female patients (n = 60) with BPD and comorbid PTSD were randomized to either a 10-week residential NET or DBT-bt. The primary outcome was change in PTSD severity as assessed by the Clinician Administered PTSD Scale (CAPS). Mixed linear models as well as reliable change, remission, and response rates were used to compare improvement across treatment groups.
Results: Mixed linear model showed that patients in both treatments improved significantly over time across all outcome measures. This improvement was not more pronounced in NET (no significant time × type of treatment effect). However, NET resulted in a higher remission rate as compared to DBT-bt. PTSD remission was accompanied by BPD remission in all cases.
Conclusions: This study shows the value of trauma-focused therapy in patients with BPD and PTSD for recovery in both disorders. To shorten the duration of both illnesses as much as possible, future studies should focus on the factors predicting treatment success and enabling patients to benefit from trauma-focused treatment as soon as possible.
Methods: Female patients (n = 60) with BPD and comorbid PTSD were randomized to either a 10-week residential NET or DBT-bt. The primary outcome was change in PTSD severity as assessed by the Clinician Administered PTSD Scale (CAPS). Mixed linear models as well as reliable change, remission, and response rates were used to compare improvement across treatment groups.
Results: Mixed linear model showed that patients in both treatments improved significantly over time across all outcome measures. This improvement was not more pronounced in NET (no significant time × type of treatment effect). However, NET resulted in a higher remission rate as compared to DBT-bt. PTSD remission was accompanied by BPD remission in all cases.
Conclusions: This study shows the value of trauma-focused therapy in patients with BPD and PTSD for recovery in both disorders. To shorten the duration of both illnesses as much as possible, future studies should focus on the factors predicting treatment success and enabling patients to benefit from trauma-focused treatment as soon as possible.
Stichworte
borderline personality disorder (BPD);
narrative exposure therapy (NET);
posttraumatic stress disorder(PTSD);
randomized controlled trial (RCT);
cognitive behavior therapy (CBT)
Erscheinungsjahr
2021
Zeitschriftentitel
Frontiers in Psychiatry
Band
12
Art.-Nr.
765348
Urheberrecht / Lizenzen
eISSN
1664-0640
Finanzierungs-Informationen
Open-Access-Publikationskosten wurden durch die Universität Bielefeld gefördert.
Page URI
https://pub.uni-bielefeld.de/record/2959939
Zitieren
Steuwe C, Berg M, Beblo T, Driessen M. Narrative Exposure Therapy in Patients With Posttraumatic Stress Disorder and Borderline Personality Disorder in a Naturalistic Residential Setting: A Randomized Controlled Trial. Frontiers in Psychiatry. 2021;12: 765348.
Steuwe, C., Berg, M., Beblo, T., & Driessen, M. (2021). Narrative Exposure Therapy in Patients With Posttraumatic Stress Disorder and Borderline Personality Disorder in a Naturalistic Residential Setting: A Randomized Controlled Trial. Frontiers in Psychiatry, 12, 765348. https://doi.org/10.3389/fpsyt.2021.765348
Steuwe, Carolin, Berg, Michaela, Beblo, Thomas, and Driessen, Martin. 2021. “Narrative Exposure Therapy in Patients With Posttraumatic Stress Disorder and Borderline Personality Disorder in a Naturalistic Residential Setting: A Randomized Controlled Trial”. Frontiers in Psychiatry 12: 765348.
Steuwe, C., Berg, M., Beblo, T., and Driessen, M. (2021). Narrative Exposure Therapy in Patients With Posttraumatic Stress Disorder and Borderline Personality Disorder in a Naturalistic Residential Setting: A Randomized Controlled Trial. Frontiers in Psychiatry 12:765348.
Steuwe, C., et al., 2021. Narrative Exposure Therapy in Patients With Posttraumatic Stress Disorder and Borderline Personality Disorder in a Naturalistic Residential Setting: A Randomized Controlled Trial. Frontiers in Psychiatry, 12: 765348.
C. Steuwe, et al., “Narrative Exposure Therapy in Patients With Posttraumatic Stress Disorder and Borderline Personality Disorder in a Naturalistic Residential Setting: A Randomized Controlled Trial”, Frontiers in Psychiatry, vol. 12, 2021, : 765348.
Steuwe, C., Berg, M., Beblo, T., Driessen, M.: Narrative Exposure Therapy in Patients With Posttraumatic Stress Disorder and Borderline Personality Disorder in a Naturalistic Residential Setting: A Randomized Controlled Trial. Frontiers in Psychiatry. 12, : 765348 (2021).
Steuwe, Carolin, Berg, Michaela, Beblo, Thomas, and Driessen, Martin. “Narrative Exposure Therapy in Patients With Posttraumatic Stress Disorder and Borderline Personality Disorder in a Naturalistic Residential Setting: A Randomized Controlled Trial”. Frontiers in Psychiatry 12 (2021): 765348.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0):
Volltext(e)
Name
fpsyt-12-765348.pdf
1.56 MB
Access Level
Open Access
Zuletzt Hochgeladen
2021-12-14T15:10:45Z
MD5 Prüfsumme
dc351bf3a79d9ef0cfc05db654abf3b8
Daten bereitgestellt von European Bioinformatics Institute (EBI)
Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
References
Daten bereitgestellt von Europe PubMed Central.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 34899426
PubMed | Europe PMC
Suchen in